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Background: Although there are several different general diabetes self-efficacy scales, there 
is a need to develop a self-efficacy scale that providers can use to assess patient’s self-efficacy 
regarding medication use. The purpose of this study was to: 1) develop a new diabetes medication 
self-efficacy scale and 2) examine how diabetes medication self-efficacy is associated with 
patient-reported problems in using diabetes medications and self-reported adherence.
Patients and methods: Adult English-speaking patients with type 2 diabetes were recruited 
from a family medicine clinic and a pharmacy in Eastern North Carolina, USA. The patients 
were eligible if they reported being nonadherent to their diabetes medicines on a visual analog 
scale. Multivariable regression was used to examine the relationship between self-efficacy and 
the number of reported diabetes medication problems and adherence.
Results: The diabetes medication self-efficacy scale had strong reliability (Cronbach’s 
alpha =0.86). Among a sample (N=51) of mostly African-American female patients, diabetes 
medication problems were common (6.1±3.1) and a greater number of diabetes medications 
were associated with lower medication adherence (odds ratio: 0.35; 95% confidence interval: 
0.13, 0.89). Higher medication self-efficacy was significantly related to medication adherence 
(odds ratio: 1.17; 95% confidence interval: 1.05, 1.30) and inversely related to the number of 
self-reported medication problems (β=-0.13; P=0.006).
Conclusion: Higher diabetes medication self-efficacy was associated with fewer patient-
reported medication problems and better medication adherence. Assessing medication-specific 
self-efficacy may help to identify medication-related problems that providers can help the patients 
address, potentially improving adherence and patient outcomes.
Keywords: diabetes, adherence, self-efficacy, literacy
Background
Diabetes is a significant public health problem that affects 9.3% of the population in 
America.1 African-American adults are twice as likely as non-Hispanic White adults to 
have been diagnosed with diabetes.2,3 Medication management is a critical self-management 
skill for individuals living with diabetes who cannot control their disease with diet and 
exercise. Poor medication understanding and adherence are common among the diabetes 
patients.4,5 Research has shown that the African-American patients worry more about side 
effects and medication dependency and are less likely to adhere to their diabetes medications 
than the White patients.6–8 Adherence to diabetes medications is important because 
better medication adherence has been associated with improved diabetes control.9
Correspondence: Betsy Sleath
UNC Eshelman School of Pharmacy, 
Division of Pharmaceutical Outcomes 
and Policy, The University of North 
carolina at chapel hill, cB 7573, 
Chapel Hill, NC 27599-7573, USA
Tel +1 919 966 8969
Fax +1 919 966 1634
email betsy_sleath@unc.edu 
Journal name: Patient Preference and Adherence
Article Designation: Original Research
Year: 2016
Volume: 10
Running head verso: Sleath et al
Running head recto: Diabetes medication self-efficacy and adherence
DOI: http://dx.doi.org/10.2147/PPA.S101349
Patient Preference and Adherence 2016:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1004
sleath et al
Prior research in glaucoma and hypertension has found 
that medication self-efficacy is significantly associated with 
medication adherence.10–13 Self-efficacy is one of the key 
constructs in social cognitive theory.14 Self-efficacy is defined 
as individuals’ personal beliefs regarding their capabilities 
to carry out a specific task to achieve a desired outcome.14 
According to social cognitive theory, if individuals have 
higher self-efficacy that they can perform a certain behav-
ior, such as taking a medication, they are more likely to 
perform the behavior and exert greater effort to overcome 
obstacles that are encountered. In diabetes, self-efficacy is 
important because interventions that improve self-efficacy 
have been associated with improved glycemic control.15 Self-
efficacy appears to influence the performance of self-care 
behaviors, including medication use, which in turn affects 
glycemic control.16–18 The effect of self-efficacy on diabetes 
self-care is consistent across races, ethnic groups, and health 
literacy levels.19
Prior qualitative research has found that the patients often 
mention in focus groups: 1) the barriers they have to chronic 
illness medication self-efficacy and 2) that lack of knowledge 
of their medications can impede their confidence in managing 
a chronic medical condition such as diabetes.20 Medication 
self-efficacy scales have been developed for both hyperten-
sion and glaucoma, but not for diabetes.10,12,21
There are several different general diabetes self-efficacy 
scales such as the Diabetes Management Self-Efficacy Scale; 
the Diabetes Empowerment Scale, which measures diabetes-
related psychosocial self-efficacy; and the Perceived Diabetes 
Self-Management Scale.18,22,23 The scales all assess general 
diabetes management self-efficacy without a specific focus 
on medications. Although some of these general diabetes 
self-efficacy scales have been positively associated with 
medication adherence, only two of 20 items on the Diabetes 
Management Self-Efficacy Scale and no items on the other 
two scales, specifically pertain to medication use.18,22–24
There is also an Insulin Management Diabetes Self-
Efficacy Scale, which assesses confidence in managing/
taking insulin.25 However, there is a need to develop a 
diabetes medication self-efficacy scale relevant to all types 
of medications commonly used to treat diabetes (eg, oral 
agents, insulin, and other types of injections), because the 
patients often take more than one type at the same time. 
A diabetes medication self-efficacy scale could be used 
to help providers assess patient’s lack of confidence in 
taking their medications under different circumstances so 
that they could help the patients to overcome barriers to 
medication use.
A few studies have investigated patient-articulated 
barriers to medication use and their potential relationship 
with medication self-efficacy.26,27 A systematic review of 
medication problems in the patients with diabetes or cardio-
vascular disease revealed three major categories of problems: 
patient-related factors (including socioeconomic and lifestyle 
factors), medication-related factors (eg, fear of medicine, 
lack of knowledge), and condition-related factors (eg, lack 
of knowledge, fear of condition, and complications).26 
Within these three broad areas, prior works specifically 
identified the following patient-reported problems with dia-
betes medications: cost of medications,27,28 how medications 
work alongside diet and exercise,28–30 the belief that natural 
remedies are an alternative to medications,29 forgetting to 
take medications or inconvenient to take all medications,27,28 
side effects,27,30 not wanting to take medications,27 issues 
understanding medicine labels,27 access issues and lack of 
support,27,28 and lack of knowledge about their condition.29
In order to take the first steps in developing a new tool that 
can capture patient-reported information related to diabetes 
medication problems and associated self-efficacy, the objectives 
of the current study were to: 1) develop a new diabetes medica-
tion self-efficacy scale, and 2) examine how diabetes medication 
self-efficacy is associated with patient-reported problems in 
using diabetes medications and self-reported adherence.
Patients and methods
This pilot study was conducted in compliance with the 
University of North Carolina Institutional Review Board and 
Office of Human Research Ethics and in accord with the tenets 
of the Treaty of Helsinki and was Health Insurance Portabil-
ity and Accountability Act compliant. All patients signed a 
statement of informed consent.
Procedure
The patients were recruited from a family practice clinic and a 
pharmacy in Eastern North Carolina, USA. The patients were 
eligible for the study if they were: 1) at the age of 18 years or 
older; 2) had been diagnosed with type 2 diabetes; 3) were 
taking at least one oral and/or injectable medication for diabe-
tes; 4) could speak English; 5) reported being nonadherent to 
their diabetes medicines on a visual analog scale (VAS); and 
6) were African-American or White. The VAS screener we 
used to determine eligibility asked the patients to put a line 
on a 10 cm scale indicating how much of the time they use 
all of their diabetes medications exactly as directed (range is 
0= none of the time to 10= all of the time).31,32 The VAS has 
strong validity and reliability and has been validated against 
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prescription drug refill records.32,33 The patients were eligible 
for our study if they indicated that they were not always using 
their diabetes medication exactly as directed (ie, they did not 
report their adherence as 10).
The interested patients were told about the study by 
clinic or pharmacy staff and were referred to a research 
assistant. The patients were consented and then screened to 
see if they were eligible for the study. The patients who met 
the eligibility criteria were enrolled. The research associate 
then interviewed the patient. Patients received US$20 for 
participating in the study.
Measurement
Demographic and other characteristics
The following demographic and other characteristics were col-
lected: age, sex, race (African-American versus non-African- 
American), whether the patient is on oral diabetes medicines, 
whether the patient is on injectable diabetes medicines, and 
how many diabetes medications the patient is taking.
Rapid Estimate of Adult Literacy in Medicine
Each subject completed the Rapid Estimate of Adult Literacy 
in Medicine (REALM). This is a validated, rapid screening 
instrument designed to identify the patients who have dif-
ficulty reading common medical and lay terms that are 
routinely used in patient education materials.34 The REALM 
was chosen because it has high face validity and high criterion 
validity, it has been well received by the patients, and it takes 
only 2–3 minutes to administer and score.34 Patient scores on 
the REALM correspond to literacy levels (score of 0–60= 
eighth grade and less and 61–66= ninth grade and more).
Patient health Questionnaire-2
The Patient Health Questionnaire-2 assesses the fre-
quency of depressed mood and anhedonia over the past 
2 weeks.35 The scores range from 0 to 6, and a score of 3 is 
an optimal cut point for screening depressive symptoms.35 
Depressive symptoms were measured as a dichotomous 
variable (0–2= no depressive symptoms and 3–6= depres-
sive symptoms).
Beliefs about medications questionnaire
The four-item concerns and five-item necessities sections 
of the Beliefs about Medications Questionnaire were 
administered.36 The scores ranged from 4 to 20 on the 
concerns subscale and 10 to 25 on the necessities subscale. 
Higher scores correspond to more positive beliefs (eg, less 
concerns, strong beliefs in necessity).
Diabetes medication self-efficacy questionnaire 
development
A new diabetes medication self-efficacy scale was devel-
oped. It was modeled after the hypertension medication 
self-efficacy scale and the glaucoma medication adherence 
self-efficacy scale.10,12 The scale was modified to be appropri-
ate for the diabetes patients with input from seven diabetes 
patients and four health care professionals who work closely 
with the diabetes patients. The final questionnaire that the 
patients completed included 20 items to assess self-efficacy 
in overcoming barriers that might interfere with the use of 
diabetes medications (Figure S1). The response options for 
the self-efficacy items were not at all confident, somewhat 
confident, and very confident.
One item was eliminated “confidence in using at work 
or school” because many individuals left it blank because 
they were retired. A Cronbach’s alpha was then calculated to 
assess reliability of the resulting 19-item diabetes medication 
self-efficacy scale. If there were missing data for an item, 
the mean score was substituted for the item. Scores on the 
diabetes medication adherence scale ranged from 19 (lower 
self-efficacy) to 57 (higher self-efficacy). Our sample was 
too small to conduct a factor analysis.
reported problems in using diabetes medicines
Each patient was asked to evaluate the degree to which 14 
potential problems or concerns in using diabetes medications 
affected them (“none”, “a little”, or “a lot”). Each of these 
were recoded into a dichotomous variable (none versus a 
little or a lot of problems). The 14 problem areas were also 
summed to create a nonweighted variable equal to the number 
of problems or concerns in taking diabetes medications that 
ranged from 0 to 14.
self-reported medication adherence
Morisky’s eight-item measure of self-reported adherence, 
which has a reliability of 0.83, was used to assess adherence.37 
The Morisky measure has been used successfully with the 
diabetes patients.9,38 The eight-item scale is summed after 
one item (did you take your diabetes medicine yesterday) is 
reverse coded. The variable was then recoded into the fol-
lowing categories: high or medium adherence (6–8) versus 
low adherence (0–5).
Analysis
First, the descriptive statistics for the patient characteristics were 
calculated. Next, the bivariate relationships between patient 
age, sex, race, REALM score, Patient Health Questionnaire-2 
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score, medication concerns, medication necessities, diabetes 
medication self-efficacy and 1) patient-reported problems in 
using diabetes medicines, and 2) self-reported adherence were 
examined using Pearson’s correlation coefficients, indepen-
dent sample t-tests, and chi-square statistics.
Because this was a pilot study and the sample size was 
small, only variables that were significant in the bivariate 
analyses were included in the multivariable linear regression, 
predicting the number of patient-reported problems in using 
diabetes medications. Similarly, only variables significant 
in the bivariate analyses were included in the multivariable 
logistic regression, predicting patient-reported adherence on 
the Morisky scale.
Results
Table 1 presents patient characteristics (N=51). The sample 
was 84.3% African-Americans and 80.4% females. One 
patient who classified himself as White also stated that he 
was partly Native American. The patients were on an aver-
age of 2.1 diabetes medications (standard deviation =0.9, 
range =1–4), 80.4% of the patients were on oral diabetes medi-
cations and 50.9% were on injectable diabetes medications.
Table 2 presents patients’ responses on the 19-item dia-
betes medication self-efficacy scale. The situations where the 
patients reported that they were not at all sure they could take 
their diabetes medications were when the medications cost 
a lot of money (31.4%), the patients come home late from 
work or other activities (23.5%), the patients are confused 
(21.6%), the medications cause some side effects (19.6%), 
the medications sometimes make the patients tired (19.6%), 
and the medications make the patient shaky or jittery 
(19.6%). The measured reliability of the self-efficacy scale 
was a Cronbach’s alpha of 0.86.
The patients reported an average of 6.1 problems with their 
diabetes medications (standard deviation =3.1, range =0–12). 
The most commonly reported problems were as follows: 
worried about health problems from diabetes (74.5%), side 
effects from diabetes medicines (70.6%), hard to pay for glu-
cose monitoring supplies (64.7%), forgot to take medicines 
(54.9%), and hard to pay for diabetes pills (54.9%).
The African-American patients were significantly more 
likely to report more diabetes medication problems than 
the non-African-American patients (t-test =2.66, P=0.01). 
The patients with depressive symptoms were significantly 
more likely to report more diabetes medication problems 
(t-test =2.57, P=0.013). The patients with higher scores on the 
beliefs about medications concerns scale were significantly 
more likely to report more diabetes medication problems 
(Pearson’s correlation =0.47, P=0.0005). The beliefs about 
medications concerns subscale had a Cronbach’s alpha of 
0.77, and the necessities subscale had a Cronbach’s alpha 
of 0.82.
The patients who had a literacy level of ninth grade 
or more were significantly less likely to report diabetes 
medication problems than those who had eighth grade or less 
(t-test =-3.15, P=0.003). The patients with higher diabetes 
medication self-efficacy were significantly less likely to report 
diabetes medication problems (Pearson’s correlation =-0.52, 
P,0.0001). No other patient characteristics were signifi-
cantly associated with the number of diabetes medication 
problems.
Table 3 presents the linear regression predicting the 
number of patient-reported problems in using diabetes medi-
cations. Having depressive symptoms was not significant 
in the multivariable analysis (β=0.26, P=0.750). African- 
Americans (β=2.24, P=0.016) and the patients who had more 
concerns about using their medications (β=0.29, P=0.003) 
reported significantly more problems in using their diabetes 
medications. The patients with higher diabetes medication 
self-efficacy (β=-0.13, P=0.006) and higher health literacy 
(β=-1.51, P=0.036) reported significantly fewer problems.
The patients with higher diabetes medication self-efficacy 
were significantly more likely to report being adherent to their 
Table 1 Patient characteristics (n=51)
Characteristics % (n)
sex, % (n)
Male 19.6 (10)
Female 80.4 (41)
race, % (n)
African-American 84.3 (43)
White 15.7 (8)
reAlM, % (n)
eighth grade or lower 43.1 (22)
ninth grade or higher 56.9 (29)
PhQ-2, % (n)
No depressive symptoms 74.5 (38)
Depressive symptoms 25.4 (13)
On oral diabetes medications 80.4 (41)
On injectable diabetes medications 50.9 (26)
range (mean, standard deviation) Range (mean ± SD)
Age 25–75 (54.0±10.4)
number of diabetes medications 1–4 (2.1±0.9)
Diabetes adherence self-efficacy 31–56 (45.4±7.5)
Beliefs about medications – concerns 4–20 (12.7±4.0)
Beliefs about medications – benefits 10–25 (18.7±4.3)
number of diabetes medication  
reported problems
0–12 (6.1±3.1)
Abbreviations: REALM, Rapid Estimate of Adult Literacy in Medicine; PHQ-2, 
Patient Health Questionnaire-2; SD, standard deviation.
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diabetes medications (t-test =-3.30, P=0.002). The patients 
with higher scores on the beliefs about medications concerns 
scale were significantly less likely to report being adherent 
to their diabetes medications (t-test =3.36, P=0.0015). The 
patients on more diabetes medications were significantly 
less likely to be adherent to their diabetes medications 
(t-test =2.36, P=0.02). No other patient characteristics were 
significantly associated with adherence.
Table 4 presents the logistic regression predicting patient 
self-reported diabetes medication adherence. Beliefs about 
medications concerns were not included in the final regression 
because they were significantly correlated with the number of 
medications (Pearson’s correlation =-0.28, P=0.04) and dia-
betes medications self-efficacy (Pearson’s correlation =0.30, 
P=0.03). The patients with higher diabetes medication self-
efficacy scores were significantly more adherent to their 
medications than the patients with lower self-efficacy (odds 
ratio =1.17; 95% confidence interval: 1.05, 1.30). The patients 
on more diabetes medications were significantly less adher-
ent to their medications (odds ratio =0.35; 95% confidence 
interval: 0.13, 0.89). No other patient characteristics were 
significantly associated with adherence.
Discussion
This study reports on the development and evaluation of a 
diabetes medication self-efficacy scale. The scale had strong 
reliability and was significantly associated with patient self-
reported diabetes medication adherence, which suggests good 
construct validity. Diabetes medication self-efficacy was also 
strongly associated with the number of diabetes medication 
problems that the patients reported having.
The diabetes medication self-efficacy scale could be used 
to screen patients with low self-efficacy, so that providers 
such as physicians, nurse practitioners, pharmacists, and 
diabetes educators could educate patients and attempt to 
improve their diabetes medication self-efficacy. This would 
Table 2 Patient responses on the diabetes medication self-efficacy scale (N=51)
How sure are you that you can take  
your diabetes medicines if …
Not at all sure, % (n) Somewhat sure, % (n) Very sure, % (n)
You are busy at home 3.9 (2) 35.3 (18) 60.8 (31)
There is no one to remind you 3.9 (2) 31.4 (16) 60.8 (31)
They cause some side effects 19.6 (10) 43.1 (22) 35.3 (18)
You worry about taking them for the rest of your life 13.7 (7) 31.4 (16) 52.9 (27)
They cost a lot of money 31.4 (16) 35.3 (18) 31.4 (16)
You come home late from work or other activities 23.5 (12) 35.3 (18) 39.2 (20)
You do not have any symptoms of diabetes 17.7 (9) 31.4 (16) 50.9 (26)
You are with family members 9.8 (5) 27.5 (14) 62.8 (32)
You are in a public place 11.8 (6) 25.5 (13) 62.8 (32)
You feel you do not need them 11.8 (6) 39.2 (20) 46.1 (24)
You are traveling 7.8 (4) 33.3 (17) 56.9 (29)
You take them more than once a day 3.9 (2) 21.6 (11) 72.6 (37)
They sometimes make you tired 19.6 (10) 35.3 (18) 45.1 (23)
You have other medicines to take 9.8 (5) 17.7 (9) 70.6 (36)
You feel okay 5.9 (3) 27.5 (14) 66.7 (34)
You are shaky or jittery 19.6 (10) 27.5 (14) 53.9 (27)
You are confused 21.6 (11) 37.3 (19) 41.2 (21)
Your vision is blurry 15.7 (8) 35.3 (18) 49.0 (25)
You have a headache 15.7 (8) 25.5 (13) 56.9 (29)
Table 3 Multivariable linear regression results predicting the 
number of patient-reported problems in using their diabetes 
medications (n=51)
Independent variables β
Patient race – African-American 2.24*
reAlM reads ninth grade or higher -1.51*
PHQ-2-depressive symptoms 0.26
Beliefs about medications – concerns 0.29**
Diabetes medication self-efficacy -0.13**
Notes: *P,0.05. **P,0.01.
Abbreviations: REALM, Rapid Estimate of Adult Literacy in Medicine; PHQ-2, 
Patient health Questionnaire-2.
Table 4 Multivariable logistic regression results predicting 
whether the patients scored as having high/medium adherence 
on the Morisky adherence scale (N=51)
Independent variables Patient had medium/high 
adherence, odds ratio  
(95% confidence interval)
number of diabetes medications 0.35 (0.13, 0.89)*
Diabetes medication self-efficacy 1.17 (1.05, 1.30)**
Notes: *P,0.05. **P,0.01.
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then hopefully result in fewer patient problems in using their 
diabetes medications and improved medication adherence.
Additionally, the patients with higher scores on the beliefs 
about medication concerns scale were found to report more 
problems in using their diabetes medications and lower adher-
ence. This suggests that providers should work with the patients 
to help them overcome any concerns they have in using diabetes 
medications. African-Americans reported significantly more 
problems in using their diabetes medications than Whites, 
which is similar to the previous research that found that African-
Americans were more worried about side effects and medica-
tion dependency than Whites.7 Providers should work closely 
with the African-American patients to address or manage any 
problems they have in using their diabetes medications.
The patients on more medications were significantly less 
adherent to their diabetes medications, which is similar to the 
results of other studies in different therapeutic areas.39 This 
suggests that, when possible, providers should simplify the 
patients’ medication regimens and prescribe fewer medica-
tions for the patient’s condition.
The patients who had a literacy level of eighth grade or 
less were significantly more likely to report more diabetes 
medication problems. Prior works in diabetes have found 
lower literate patients to have worse adherence and more 
hypoglycemia.8,40 Our findings suggest that providers might 
want to spend more time with less literate patients to help 
them overcome any problems they might have in using their 
diabetes medications.
The patients with more medication concerns reported 
significantly more problems in using their diabetes 
medications and lower adherence. Providers need to help the 
diabetes patients overcome negative views or concerns they 
have about using diabetes medications so that they will take 
medications to help control their blood sugar.
Limitations
The study has many limitations. First, as the patients were 
recruited from one pharmacy and one family medicine clinic 
in the Eastern part of North Carolina, the results may not be 
generalizable to other geographic areas. Second, this was a 
pilot study with a small sample size. Future research should test 
the psychometric properties of the diabetes medication self-
efficacy scale with larger and more diverse patient samples.
Conclusion
Despite the limitations, this study provides new informa-
tion on the development of a diabetes medication self-
efficacy scale. An association between diabetes medication 
self-efficacy and both patient-reported problems in using 
diabetes medications and self-reported adherence was 
identified in this study. Future research in larger and more 
diverse patient populations needs to be conducted to deter-
mine if an intervention to improve self-efficacy longitudinally 
is associated with 1) objective changes in adherence mea-
sured by medication refills or electronic monitoring, and 2) 
improved hemoglobin A1C. If successful, identifying the dia-
betes patients with low medication self-efficacy in a clinical 
setting may allow providers to address medication-related 
problems and potentially improve adherence. As diabetes 
management can be improved through better medication 
adherence,9 the diabetes medication self-efficacy scale has 
the potential to allow providers to augment patient self-
efficacy in taking their diabetes medications in areas where 
they report difficulties.
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We would like to know how sure you are in taking your diabetes medicines or in your ability to carry out certain tasks 
related to your diabetes medicines. (Please circle one answer per item.)
How sure are you that you can take your diabetes medicines if… Not at all sure Somewhat sure Very sure
1) … you are busy at home? 1 2 3
2) … there is no one to remind you? 1 2 3
3) … they cause some side effects? 1 2 3
4) … you worry about taking them for the rest of your life? 1 2 3
5) … they cost a lot of money? 1 2 3
6) … you come home late from work or other activities? 1 2 3
7) … you do not have any symptoms of diabetes? 1 2 3
8) … you are with family members? 1 2 3
9) … you are in a public place? 1 2 3
10) … you feel you do not need them? 1 2 3
11) … you are traveling? 1 2 3
12) … you take them more than once a day? 1 2 3
13) … they sometimes make you tired? 1 2 3
14) … you have other medicines to take? 1 2 3
15) … you feel okay? 1 2 3
16) … you are shaky or jittery? 1 2 3
17) … you are confused? 1 2 3
18) … your vision is blurry? 1 2 3
19) … you have a headache? 1 2 3
Figure S1 Diabetes medicine self-efficacy.
